Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

Status: Active_not_recruiting
Location: See all (8) locations...
Study Type: Observational
SUMMARY

The Innovative Support for Patients with SARS COV-2 Infections Registry (INSPIRE) study is a CDC-funded COVID-19 project to understand the long-term health outcomes in recently tested adults, both negative and positive, who have suspected COVID symptoms at the time of their test. Participants will complete short online surveys every 3 months for 18 months, share information about their health using a secure web-based platform, and are compensated for their time.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Fluent in English or Spanish;

• Age 18 and over;

• Self-reported symptoms suggestive of acute SARSCOV2 infection;

• Under investigation for SARSCOV2 (defined as a patient who has received any screening or diagnostic test used to detect the presence of COVID19 including any FDA approved or authorized molecular or antigen-based assay) within the last 42 days.

Locations
United States
California
UCLA
Los Angeles
UCSF
San Francisco
Connecticut
Yale
New Haven
Illinois
Rush University Medical Center
Chicago
Pennsylvania
Thomas Jefferson University
Philadelphia
Texas
University of Texas Southwestern
Dallas
University of Texas Health Science Center at Houston
Houston
Washington
University of Washington
Seattle
Time Frame
Start Date: 2020-12-15
Completion Date: 2025-12-31
Participants
Target number of participants: 6000
Treatments
Symptomatic Individuals with infection with SARS-COV2 (ie exposed cohort)
Symptomatic Individuals test positive for SARS-COV2. Participants will be enrolled soon after infection and followed to assess for long term outcomes.
Symptomatic Individuals without infection with SARS-COV2 (ie unexposed cohort)
Symptomatic Individuals test negative for SARS-COV2. Participants will be enrolled soon after testing and followed to assess for long term outcomes.
Sponsors
Collaborators: The University of Texas Health Science Center, Houston, Yale University, University of Washington, Thomas Jefferson University, University of California, San Francisco, University of California, Los Angeles, University of Texas Southwestern Medical Center
Leads: Rush University Medical Center

This content was sourced from clinicaltrials.gov